TP53mut is associated with more aggressive tumours and poor overall outcome in various cancer types compared to wt TP53 [48], including endometrial cancers, and ~27.8% of patients with endometrial cancer have been reported to have TP53mut regardless of histological type [49]. Here, TP53 is linked to endometrial cancer.